Zhejiang Starry Pharmaceutical Co., Ltd. announced earnings results for the half year ended June 30, 2020. For the half year, the company announced sales was CNY 722.062 million compared to CNY 635.860 million a year ago. Operating income was CNY 183.894 million compared to CNY 121.822 million a year ago. Net income was CNY 139.685 million compared to CNY 93.122 million a year ago. Basic earnings per share from continuing operations was CNY 0.59 compared to CNY 0.4 a year ago.